Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 494.97
   
  • Change Today:
    $14.84
  • 52 Week High: $495.55
  • 52 Week Low: $479.75
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 350,021
  • Market Cap: $116,808m
  • RiskGrade: 164

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 494.97
Change Today $ 14.84
% Change 3.09 %
52 Week High $495.55
52 Week Low $479.75
Volume 350,021
Shares Issued 235.99m
Market Cap $116,808m
RiskGrade 164

What The Brokers Say

Strong Buy 9
Buy 11
Neutral 8
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 27-Feb-2026

Time Volume / Share Price
11:57 46 @ $494.97
11:56 40 @ $494.70
11:56 40 @ $494.77
11:56 100 @ $494.29
11:56 70 @ $494.26

Top of Page